BMPR2 and pulmonary arterial hypertension: Furthermore, in PAH patients with and without BMPR2 mutations, BMPR2 expression and signaling activity is impaired in the pulmonary vasculature [40,41], suggesting that dysfunction of BMPR2 signaling is a key common feature in PAH patients.